# Genesis Medtech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genesis-medtech

- Industry: Medical Devices & Equipment
- Headquarters: Singapore, Singapore
- Website: www.genesismedtech.com
- Latest round: Series B (May 23, 2021)
- Investors on record: 5

## About

Established in 2019 and based in Singapore, Genesis Medtech operates as a medical device company that engages in the research and development, sale of medical intervention products. It has sub-branch offices in Minneapolis, Tokyo, Wuxi, and Shanghai. Its product, J-VALVE®TF valve was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) in August 2023. In September 2024, Genesis Medtech raised USD 25 million in venture funding from new investor Edwards Lifesciences Corporation.

The company's products are focused on minimally invasive surgery, neurovascular, cardiovascular, peripheral vascular, and structural heart. The minimally invasive surgery product includes access system, surgical energy system, stapler, suture, and articulating laparoscopic instrument. In neurovascular, the company focuses on stroke prevention, diagnosis, treatment and rehabilitation. Besides, Genesis also provides surgical devices such as ultrasonic energy devices, which can be used for gastric, colorectal, thoracic and other surgical operations. The products are exported to international markets such as Europe, America and South Korea.

The company generates revenue by providing multi-therapy medical device products.

The company will sell its transcatheter aortic valve system J-Valve system overseas rights to Edwards Lifesciences.

## Funding rounds

- Series B, May 23, 2021 — General Atlantic, CITIC Capital Holdings, Lilly Asia Ventures
- Series A, Jul 25, 2019 — Hong Shan, Boyu Capital

## Investors

- Hong Shan — Series A
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series A
- General Atlantic (https://capitalatlas.ai/funds/general-atlantic) — Series B
- CITIC Capital Holdings (https://capitalatlas.ai/funds/citic-capital-holdings) — Series B
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series B